Pharming Group N.V. ( PHAR) - Stock Earnings
PHAR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 7.5 million USD | 97.3 million USD |
| 2025Q4 | 5.3 billion USD | 106.5 billion USD |
| 2026Q1 | -5.2 million USD | 72.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PHAR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.5 million USD | 245.3 million USD |
| 2024 | -11.8 million USD | 297.2 million USD |
| 2025 | 2.9 million USD | 377.2 million USD |
| 2026 Est. | — | — |
PHAR
Price: $12.37
52 week price:
Earnings Per Share: 0.19 USD
P/E Ratio: 68.85
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 1500
Market Capitalization: 864.5 million